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Abstract:
We have previously shown that AMP-activated protein kinase (AMPK) can
induce the resumption of meiosis in mouse oocytes maintained in meiotic
arrest in vitro. The present study was carried out to determine whether AMPK
activation is involved in hormone-induced maturation. Follicle-stimulating
hormone (FSH) and the EGF-like peptide, amphiregulin (AR), are potent
inducers of maturation in cumulus cell-enclosed oocytes (CEO). Within 3 h of
FSH treatment, phosphoacetyl CoA carboxylase (ACC) levels were increased
in germinal vesicle (GV)-stage oocytes when compared to non-stimulated
controls and remained elevated throughout 9 h of culture, indicating AMPK
activation. A similar response to AR was observed after 6 h of culture. Using
PT172 antibody (binds only to activated AMPK), Western analysis
demonstrated active AMPK in both FSH- or AR-treated GV-stage oocytes
within 6 h. The AMPK inhibitors, compound C and adenine 9-beta-DDevelopmental Biology, Vol. 313, No. 1 (January 2008): pg. 47-57. DOI. This article is © Elsevier and permission has been
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arabinofuranoside (araA), blocked FSH- or AR-induced meiotic resumption
and ACC phosphorylation, further supporting a causal role for AMPK in
hormone-induced meiotic resumption. Immunocytochemistry using antiPT172-AMPK antibody showed an increased diffuse cytoplasmic staining and
more intense punctate staining in the germinal vesicles of oocytes following
treatment with the AMPK activator, 5-aminoimidazole-4-carboxamide-1-betaD-ribofuranoside (AICAR), or with FSH or AR, and this staining was eliminated
by compound C or a blocking peptide for the anti-PT172 antibody. Staining of
oocytes from hCG-stimulated mice with the anti-PT172 antibody also showed
pronounced label in the germinal vesicles within 1-2 h. Further, in oocytes
from all groups, active AMPK was always observed in association with the
condensed chromosomes of maturing oocytes. Taken together, these results
support a role for AMPK in FSH and AR-induced maturation in vitro and hCGinduced maturation in vivo.

INTRODUCTION
In mammals, the preovulatory gonadotropin surge stimulates
meiotic resumption in fully-grown meiotically competent oocytes in
vivo. When released from their follicles prior to the gonadotropin surge
and cultured under optimal conditions, these oocytes spontaneously
resume maturation without hormone stimulation, suggesting an
inhibitory environment provided by the follicular somatic compartment.
Several candidate molecules produced by cumulus or granulosa cells
have been proposed to play this inhibitory role. The purine metabolite,
hypoxanthine (HX), is present in the follicular fluid at a concentration
sufficient to maintain oocyte meiotic arrest in vitro (Eppig et al.,
1985). Another putative factor, termed oocyte meiosis inhibitor (OMI),
may also contribute to oocyte meiotic arrest (Tsafriri and Pomerantz,
1986), though the compound has not been biochemically
characterized. Moreover, oocyte cyclic adenosine monophosphate is a
critical negative regulator of meiotic resumption (Conti et al, 2002;
Eppig et al, 2004). Agents that increase cAMP levels, cAMP analogs, or
factors that prevent degradation of cAMP reversibly maintain oocyte
meiotic arrest in vitro. Recent evidence suggests that the oocyte is the
principal site of cAMP production that operates under the control of the
somatic compartment (Mehlmann et al, 2004; Hinckley et al, 2005;
Ledent et al, 2005).
FSH promotes the maturation of cumulus cell-enclosed oocytes
(CEO) under meiosis-arresting conditions and enhances the
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preimplantation developmental competence of oocytes matured in
vitro (De La Fuente et al., 1999; Downs et al., 1988). When oocytecumulus cell complexes are stimulated with FSH, cumulus cells
generate a gap junction-transmitted positive signal that acts on
oocytes to induce meiotic resumption (Downs, 2001). It has also been
reported that within ~0.5-2 h of FSH treatment, the cumulus cells are
stimulated to produce a meiosis-inducing paracrine signal(s) that acts
on the oocyte to induce meiotic maturation (Byskov et al., 1997),
although the biochemical character of the signal(s) is unclear at
present.
In vivo, the physiological stimulus for oocyte meiotic resumption
is the luteininizing hormone surge (Stapleton et al., 1996). Distribution
of the LH receptor, a G-protein coupled receptor, is restricted to the
mural granulosa cells (Peng et al., 1991). The interaction of LH and its
receptor leads to factors released by mural granulosa cells, functioning
in an autocrine and paracrine manner to transduce the LH effects
within follicle. It has been demonstrated that in rodents members of
the epidermal growth factor (EGF) family of ligands play a critical role
in mediating LH-induced oocyte maturation (Ashkenazi et al., 2005;
Park et al., 2004). LH stimulation induces the transient and sequential
expression of the EGF family members amphiregulin (AR), epiregulin
and beta-cellulin (Park et al., 2004). Oocytes meiotically arrested in
vitro can be induced to resume meiosis by treatment with EGF-like
peptides in a cumulus cell-dependent manner (Ashkenazi et al., 2005;
Downs and Chen, 2007; Park et al., 2004). Mice lacking AR showed
delayed hCG-induced maturation and reduced cumulus expansion
(Hsieh et al., 2007), indicating the physiological role of AR in
regulation of meiotic induction.
By regulating the degradation of cAMP, phosphodiesterase (PDE)
plays an essential role in oocyte meiotic resumption. In rodents,
oocyte cAMP hydrolysis is thought to be primarily accomplished by
PDE3A (Richard et al., 2001; Shitsukawa et al., 2001). Oocytes lacking
PDE3A contained increased cAMP levels and failed to undergo
spontaneous maturation in vitro (Masciarelli et al., 2004). During
oocyte maturation in vitro or in vivo, an increase of PDE activity is
observed (Han et al., 2006; Richard et al., 2001; Tsafriri et al., 1996)
and mediates a decrease in oocyte cAMP that precedes meiotic
resumption.
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The activity of AMP-activated protein kinase (AMPK), a cellular
energy sensor, is sensitively regulated by AMP, a byproduct of cAMP
degradation. This protein Ser/Thr kinase, comprised of a catalytic α
subunit and regulatory β and γ subunits, was initially discovered as an
inhibitor of acetyl CoA carboxylase and 3-hydroxy-3-methyglutarylCoA reductase (Carling et al., 1987). An upstream kinase (AMPKK)
activates AMPK through specific phosphorylation on the threonine-172
(Thr172) residue of the α subunit (Hawley et al., 1996). In a previous
study, we have shown that activation of AMPK provides a positive
stimulus for mouse oocyte meiotic resumption in vitro (Chen et al.,
2006; Downs et al., 2002). Although evidence indicates that an
increase in oocyte AMPK activity can trigger GVB, the physiological
significance of this relationship is not known.
In this study, we show by Western analysis and
immunofluorescent staining that AMPK activity is increased in FSH- or
AR-stimulated oocytes before GVB and that hormone-induced
maturation is blocked by inhibitors of AMPK activation. AMPK is also
activated within-GV-stage oocytes of hCG-treated mice. These results
provide compelling evidence for AMPK mediation of hormonestimulated GVB in mouse oocytes.

MATERIALS AND METHODS
Oocyte isolation and culture conditions
C57BL/6JxSJL/J Fl mice, 19–23 days old, were used for all
experiments. Mice were primed with 5 IU equine choronic
gonadotropin and killed 48 h later by cervical dislocation. Ovaries were
removed and placed in the culture medium, and cumulus cell-enclosed
oocytes (CEO) were obtained by puncturing large antral follicles with
sterile needles. Oocytes were cultured in Eagle’s minimum essential
medium with Earle’s salts (GIBCO), supplemented with 0.23 mM
pyruvate, penicillin, streptomycin sulfate and 3 mg/ml crystallized
lyophilized bovine serum albumin (ICN ImmunoBiologicals, Lisle, IL)
and buffered with 26 mM bicarbonate. Tubes were gassed with a
humidified mixture of 5% CO2, 5% O2 and 90% N2 and placed in a
water bath at 37°C for the duration of culture.
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Western Analysis
After different treatments, oocytes were denuded by repeated
pipetting through mouth-operated small bore pipettes in cold culture
medium and washed in phosphate-buffered saline (PBS, pH 7.4)/PVP
(3 mg/ml) plus protease inhibitors (Protease Inhibitors Cocktail
Tablets, 1 mM Na orthovanadate, 2 μg/ml pepstatin, 50 mM betaGlycerophospate) and then added to an equal volume of 2× Laemmli’s
buffer containing 20% beta-mercaptoethanol. After heating at 95°C for
5 min, samples were stored frozen at −80°C until used for Western
blotting. To detect phospho-ACC levels, proteins were electrophoresed
on a 3–8% Tris-Acetate mini Gel (Invitrogen) for 1 h at 150 V and
then transferred to nitrocellulose at 100 V for 1 h. For active AMPK
(PT172) blots (figure 1B, C), samples were electrophoresed on a 4–
12% Bis-Tris SDS mini Gel (Invitrogen) for 50 min at 100 V and then
in a semi-dry system transferred to nitrocellulose at 250 mA for 2 h at
4°C. After blocking with 5% nonfat milk for 2 h at room temperature,
blots were then incubated with primary antibodies (anti-PT172 or antiphospho-ACC, 1:250) overnight at 4°C, washed in Tris-buffered saline
(TBS pH 7.4) and incubated with HRP-conjugated goat-anti-rabbit IgG
(1:1000, in 5% nonfat milk) for 1 h at room temperature. After
washing in TBS, detection was performed with Supersignal Western
Dura Chemiluminescent Substrate (Pierce) and exposed to film. Blots
were stripped and reprobed with ACC antiserum (1:2000) as a loading
control.
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Figure 1

AMPK activation in FSH-or AR-treated GV-stage oocytes. (A) Western

analysis of phospho-ACC in FSH-stimulated oocytes. CEO were denuded and extracted
after culture with or without FSH in dbcAMP-supplemented medium for the indicated
times. All oocytes were at the GV-stage, except a group of GVB-stage oocytes were
collected after 9 h FSH treatment. Western analysis of PT172-AMPK in GV-stage
oocytes after 6 h culture in the absence (Con) or presence of 0.1 μl/ml FSH (B) or 50
ng/ml AR (C) in dbcAMP-containing medium.

Immunofluorescent staining
After different treatments, CEO were denuded and fixed with
4% paraformadehyde for 1 h at 4° C, and then permeablized with
0.1% Triton in blocking buffer (0.05% saponin in PBS, PH 7.4, plus
10% sheep serum) for 30 min. Oocytes were then washed free of
Triton and continuously blocked for another 90 min at room
temperature. Oocytes were incubated with primary antibodies (1:100)
overnight at 4° C and then washed in wash buffer (PBS containing
1mg/ml BSA and 0.05% saponin) and incubated with FITC-conjugated
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sheep-anti-rabbit antibody (1:1000) at room temperature for 1 h.
After washing, propidium iodine (PI, 20 μg/ml) was applied to
counterstain the chromosomes. Images were observed with a confocal
microscope.

Confocal Microscopy
Oocytes were viewed on a laser scanning confocal microscope
(Carl Ziess Co.) with a 40× objective. During imaging all settings were
kept constant, i.e. laser power, detector gain, amplifier offset,
amplifier gain and pinhole size. Digitally recorded images were
exported by LSM Examiner (Carl Ziess Co.).

Chemicals
Saponin, propidium iodide, araA, dbcAMP, sheep serum, and
FITC-labeled sheep-anti-rabbit antibody were purchased from Sigma
Chemical Co. (St. Louis, MO). Compound C and AICAR were supplied
by Toronto research Chemicals, Inc. (North York, Ontario). Anti-pACC
antibody was purchased from Upstate Biotechnology Inc. (Lake Placid,
NY), anti-ACC antibodies were provided by Dr. Grahame Hardie, antiPT172 antibody was from Cell Signaling Technology (Beverly, MA), and
anti-PT172-specific blocking peptide came from Santa Cruz Biotech.
Inc. (Santa Cruz, CA). HRP-conjugated goat-anti-rabbit antibody and
Supersignal western dura chemiluminescent substrate were obtained
from Pierce (Rockford, IL) and vectashield mounting medium from
Vector Laboratories, Inc. (Burlingame, CA). Highly purified ovine FSH
was obtained from the National Hormone and peptide Program (NHPP),
NIDDK, and Dr. A.F. Parlow.

Statistical Analysis
Oocyte maturation experiments were repeated at least 3 times
with at least 30 oocytes per group per experiment. Data are reported
as mean percentage GVB ± SEM. Following arcsin transformation,
maturation frequencies were analyzed statistically by ANOVA followed
by Duncan’s multiple range test. For all statistical analyses, a P value
less than 0.05 was considered significant.
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RESULTS
AMPK activity is increased in FSH-treated oocytes
before GVB
dbcAMP-arrested oocytes treated with FSH initiate meiosis
between 4 and 6 h of culture and about 60% are induced to resume
maturation after 10 h (Downs and Chen, 2007). If AMPK is involved in
FSH-induced maturation, it should be activated before meiotic
resumption. Acetyl-CoA carboxylase (ACC), a key enzyme involved in
fatty acid metabolism, is an important substrate of active AMPK
(Davies et al., 1992). To assess AMPK activity in FSH-treated GV-stage
oocytes, a time course of phospho-ACC levels was determined by
Western analysis. CEO were cultured in 300 μM dbcAMP with or
without FSH for 3, 6 or 9 h. After culture, cumulus cells were removed
and GV-stage denuded oocytes from all culture groups or GVB-stage
oocytes from the 9 h treatment group were collected and analyzed by
Western analysis. At all time points, GV-stage oocytes treated with
FSH contained increased phospho-ACC levels compared to the control
groups (figure 1A), indicating that FSH stimulated AMPK activation in
oocyte before meiotic resumption. Interestingly, the amount of
phospho-ACC decreased to the basal level in oocytes that resumed
meiosis after 9 h of FSH stimulation.
To confirm AMPK activation and directly detect active AMPK,
Western analysis using anti-PT172 antibody was performed. Cellular
extracts were collected from GV-stage oocytes cultured for 6 h with or
without FSH in dbcAMP-containing medium. Consistent with phosphoACC levels, PT172-AMPK levels were increased in FSH-stimulated GVstage oocytes, indicating FSH treatment activates intra-oocyte AMPK
before oocyte maturation (figure 1B).

AMPK inhibitors block AMPK activation and FSH-induced
maturation
Compound C, a small molecule AMPK inhibitor (Zhou et al.,
2001), blocks AICAR-induced maturation by decreasing AMPK activity
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in oocytes (Chen et al., 2006). To test whether AMPK activation
mediates FSH-induced maturation, CEO were preincubated increasing
concentrations of compound C for 0.5 h in 300 μM dbcAMP before
addition of 0.1 μg/ml FSH. After 17–18 h of culture, GVB percentage
was assessed. FSH increased the maturation percentage from 10% to
70%, and this stimulation was eliminated in a dose-dependent manner
by compound C (figure 2A).

Figure 2

Effects of compound C and araA on FSH-induced maturation and ACC

phosphorylation. CEO were precultured for 0.5 h with increasing doses of compound C
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(A) or araA (B) in 300 μM dbcAMP. FSH (0.1 μg/ml) was then added and cultures were
continued for 17–18 h before assessment of GVB percentage. Groups with no common
letters are significantly different. (C) Western analysis of phospho-ACC in compound C
or araA-treated GV-stage oocytes. CEO were preincubated 0.5 h with 5 μM compound
C or 1 mM araA in 300 μM dbcAMP before addition of FSH. After 6 h of culture, GVstage oocytes were prepared for the Western analysis.

araA is the precursor of araATP, which is a competitive inhibitor
of AMPK (Henin et al., 1996), and its effects on FSH-induced
maturation were also determined. CEO were maintained in meiotic
arrest with 300 μM dbcAMP and pretreated with increasing
concentrations of araA for 0.5 h before addition of 0.1 μg/ml FSH.
Maturation percentages were determined after 17–18 h of culture.
araA dose-dependently blocked FSH-induced maturation, with a
complete suppression at 1 mM (figure 2B). These data further support
the idea that AMPK activation mediates FSH-induced maturation.
To assess the effect of compound C or araA on AMPK activity in
these oocytes, phospho-ACC levels were determined in GV-stage
oocytes by Western analysis. CEO were cultured in 300 μM dbcAMP
and pretreated with 5 μM compound C or 1 mM araA for 0.5 h before
addition of FSH. After 6 h of culture, cumulus cells were removed and
denuded GV-stage oocytes were processed for Western analysis.
Figure 2C shows that FSH treatment increased phospho-ACC levels
compared to oocytes cultured in dbcAMP alone, and exposure of FSHtreated oocytes to either compound C or araA eliminated the increase
in ACC phosphorylation, indicating suppression of AMPK activity within
oocytes.

AMPK activation mediates Amphiregulin-induced
maturation
Amphiregulin (AR), an EGF-like peptide, mediates LH-stimulated
maturation in vivo (Hsieh et al., 2007) and induces CEO meiotic
resumption in vitro (Downs and Chen, 2007; Park et al., 2004). To test
whether AMPK activation is involved in AR-induced maturation, after 6
h treatment in the absence or presence of AR, CEO were denuded and
extracts from 500 GV-stage oocytes were subjected to Western
analysis. As shown in figure 1C, active AMPK and phospho-ACC levels
were elevated in AR-treated oocytes before meiotic maturation.
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The AMPK inhibitors, compound C and araA, were tested on ARinduced maturation to assess the involvement of AMPK. CEO were
pretreated with increasing concentrations of compound C or araA in
dbcAMP-containing medium for 0.5 h before addition of 50 ng/ml AR,
and cultures were continued for 17–18 h before assessment of GVB.
AR increased the maturation percentage in CEO from 10% to 81%,
which was dose-dependently blocked by compound C (figure 3A) or
araA (figure 3B). Western analysis showed that the AR-stimulated
phosphorylation of ACC was suppressed by compound C or araA
(figure 3C), demonstrating inactivation of AMPK.
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Figure 3

Effects of compound C and araA on AR-induced maturation and ACC

phosphorylation. CEO were pretreated with increasing concentrations of compound C
(A) or araA (B) in 300 μM dbcAMP for 0.5 h. AR (50ng/ml) was then added and
cultures were continued for 17–18 h before assessment of GVB. Groups with no
common letters are significantly different. (C) Western analysis of phospho-ACC in
compound C or araA-treated oocytes. CEO were preincubated 0.5 h with 5 μM
compound C or 2 mM araA in 300 μM dbcAMP before addition of AR. CEO were
denuded after 6 h of culture and GV-stage oocytes were collected and processed for
Western analysis.

Immunofluorescent localization of active AMPK (PT172AMPK)
AICAR stimulation Immunofluorescent staining using anti-PT172
antiserum was performed to directly observe active AMPK in the
oocytes following treatment with the AMPK activator, AICAR. After 6 h
of culture in medium containing dbcAMP with or without 1 mM AICAR,
oocytes were denuded, fixed with 4% paraformaldehyde and stained
for immunofluorescence using anti-PT172 antiserum. Counterstaining
with propidium iodide (PI) enabled an assessment of AMPK localization
in relation to the germinal vesicle in immature oocytes or condensed
chromosomes following meiotic resumption. Control groups for
nonspecific staining were carried out in which either primary antibody
was omitted or a blocking peptide representing the phosphorylated
peptide recognition site was added to neutralize the primary antibody.
In the control group, in which primary antibody was omitted, a very
faint fluorescence was uniformly distributed throughout the oocyte
(data not shown). Fluorescence was never seen in the nucleolus in any
of the groups. Oocytes meiotically arrested in dbcAMP-supplemented
medium contained a diffuse fluorescence throughout the cell, which
was above the background (figure 4A). AICAR stimulation resulted in a
stronger diffuse signal in the cytoplasm, but most notable was an
intense punctate labeling in the germinal vesicle (figure 4B). In all
GVB-stage oocytes, even those spontaneously maturing in dbcAMP
alone, a punctate staining pattern was observed associated with the
condensed chromosomes (figure 4C). Pretreatment of oocytes with
compound C (figure 4D) or pretreatment of antibody with a blocking
peptide containing the specific peptide sequence recognized by the
antibody (figure 4E) eliminated both the increased cytoplasmic
staining as well as the punctate nuclear staining. When quantified,
75% of AICAR-treated GV-stage oocytes exhibited nuclear staining,
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compared to 11% of controls, and compound C completely prevented
the AICAR-stimulated response (figure 5).
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Figure 4

Localization of active AMPK in AICAR-stimulated CEO. After 6 h of culture,

cumulus cells were removed and DO were fixed and stained with rabbit anti-PT172
AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. (A) dbcAMP
alone (control), GV-stage; (B) AICAR, GV-stage; (C) AICAR, GVB-stage; (D) AICAR,
GV-stage; primary antibody was neutralized with a specific blocking peptide; (E)
AICAR plus compound C, GV-stage; CEO were preincubated with 5 μM compound C in
300 μM dbcAMP before the addition of 1 mM AICAR. Oocytes were stained with
propidium iodide (PI) for detection of chromatin. The bar represents 50 μm.

Figure 5

Effect of compound C on the percentage of GV-stage oocytes that

contained nuclear PT172 staining after 6 h of culture in 1 mM AICAR.

FSH stimulation To test if FSH-treated oocytes exhibited a similar
staining pattern, immunocytochemistry was performed on dbcAMParrested CEO stimulated with FSH for 6 h. Similar to AICAR-stimulated
CEO, GV-stage oocytes treated with FSH exhibited increased diffuse
staining in the cytoplasm and intense punctate fluorescence in the
nucleus (figure 6B) compared to a faint diffuse staining pattern in
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untreated controls (figure 6A). When oocytes resumed meiosis, active
AMPK was again consistently observed in association with the
condensed chromosomes. Compound C, at a concentration that
eliminated FSH-induced maturation, also prevented the punctate
nuclear staining and reduced the diffuse cytoplasmic staining (figure
6D, ,77).
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Figure 6

Localization of active AMPK in FSH-stimulated CEO. After 6 h of culture,

cumulus cells were removed and DO were fixed and stained with rabbit anti-PT172
AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. (A) dbcAMP
alone (control), GV-stage; (B) FSH (0.1μg/ml), GV-stage; (C) FSH (0.1μg/ml), GVBstage; (D) FSH (0.5 μg/ml) plus compound C, GV-stage; CEO were preincubated with
5 μM compound C in 300 μM dbcAMP before the addition of FSH. Oocytes were stained
with propidium iodide (PI) for detection of chromatin. The bar represents 50 μm.

Figure 7

Effect of compound C on the percentage of GV-stage oocytes that

contained nuclear PT172-AMPK staining after 6 h of culture in FSH.

Amphiregulin stimulation Experiments were next performed to
determine the active AMPK staining pattern in AR-treated oocytes.
dbcAMP-arrested CEO treated 6 h with AR exhibited the same pattern
of staining, with an increase in diffuse cytoplasmic staining and
pronounced punctate staining in the germinal vesicle of immature
oocytes (figure 8B) and around the condensed chromosomes of
oocytes that had resumed maturation (figure 8C). Compound C again
prevented this increased staining (figure 8D).
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Figure 8

Localization of active AMPK in AR-stimulated CEO. After 6 h of culture,

cumulus cells were removed and DO were fixed and stained with rabbit anti-PT172
AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. (A) dbcAMP
alone (control), GV-stage; (B) AR, GV-stage; (C) AR, GVB-stage; (D) AR plus
compound C, GV-stage; CEO were preincubated with 5 μM compound C in 300 μM
dbcAMP before the addition of AR. Oocytes were stained with propidium iodide (PI) for
detection of chromatin. The bar represents 50 μm.
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When a dose response experiment was carried out with AR
using concentrations of 2.5, 10, and 50 ng/ml, a dose-dependent
stimulation of meiotic resumption in dbcAMP-arrested oocytes was
observed that was paralleled by corresponding increases in the
frequency of nuclear staining in GV-stage oocytes using anti-PT172
antibody (figure 9A). Thus, as the maturation-inducing potency of AR
was increased, so was its ability to stimulate AMPK activation within
the GV of immature oocytes. Compound C abolished the increased
nuclear staining brought about by 50 ng/ml AR (figure 9B).
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Figure 9

Effects of AR and compound C on nuclear PT172-AMPK staining. (A)

Effect of AR dose on oocyte maturation and nuclear staining. CEO were cultured 6 h in
medium containing 300 μM dbcAMP plus increasing dose of AR and the frequencies of
both GVB and nuclear staining in GV-stage oocytes were determined. (B) Inhibitory
effect of compound C on the percentage of GV-stage oocytes that contained nuclear
PT172-AMPK staining after 6 h of culture in AR.

hCG stimulation in vivo To determine if AMPK activation within the
oocytes occurs prior to meiotic resumption in vivo, eCG-primed mice
were treated with 5 IU hCG and oocyte-cumulus cell complexes were
isolated at 1, 2 and 3.5 h post-hCG and processed for
immunofluorescence using anti-PT172 antibody. A separate set of
primed mice was injected with the PBS vehicle as controls. As shown
in figure 10, very little label was detected in the 0 h group, but as
early as 1 h after hCG injection a slight increase in staining intensity
was evident in the germinal vesicle that became very pronounced after
2 h. In two experiments, 41 out of a total of 74 oocytes (55.4 %)
isolated 2 h post-hCG displayed this increased nuclear staining. As
with oocytes stimulated in vitro, blocking peptide eliminated the
increase in nuclear fluorescence (data not shown), confirming the
specificity for active AMPK in vivo. Such staining was not observed in
oocytes from vehicle-treated mice at any time point. Nearly all of the
oocytes (90%) isolated 3.5 h post-hCG had undergone GVB and, of
these, 100% showed intense phospho-PT172 staining that colocalized
with the condensed chromosomes (figure 10). Although an increase in
diffuse cytoplasmic fluorescence was apparent in oocytes that had
resumed maturation, this increase was more subtle in immature
oocytes from hCG-stimulated animals. Interestingly, a common finding
in oocytes from hCG-treated mice were foci of intense staining in the
cytoplasm and sometimes in the germinal vesicle that were usually
larger than the aggregations of label in oocytes receiving an inducing
signal in vitro.
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Figure 10 Localization of active AMPK in oocytes from hCG-stimualted mice. eCGprimed mice were injected with 5 IU hCG and 0, 1, 2 or 3.5 h later oocytes were
isolated, fixed and stained with rabbit anti-PT172 AMPK antiserum followed by FITClabeled sheep anti-rabbit antiserum. Oocytes were stained with propidium iodide (PI)
for detection of chromatin. Note that two cumulus cell nuclei stain intensely with
propidium iodide on the bottom portion of the micrograph of the 1 h group. The bar
represents 50 μm.
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DISCUSSION
In this study, we have demonstrated the participation of AMPK
in hormone-induced maturation of mouse CEO in vitro. FSH triggered
AMPK activation in oocytes before meiotic resumption, and the AMPK
inhibitors, compound C and araA, blocked both FSH-induced
maturation and the FSH-stimulated increase in AMPK activity in GVstage oocytes. Identical results were observed in AR-stimulated
oocytes. By immunofluorescence microscopy using anti-PT172
antibody, increased diffuse cytoplasmic staining and punctate staining
in the germinal vesicle were observed in oocytes stimulated with FSH
or AR, similar to the staining pattern in AICAR-stimulated oocytes.
With each stimulatory protocol, the increase in active AMPK staining
was eliminated by compound C. AMPK was also shown to be activated
prior to meiotic resumption in oocytes from hCG-stimulated mice.
These results demonstrate the essential involvement of AMPK in
hormone-induced maturation.
FSH is an effective inducer of meiotic resumption in arrested
mouse CEO in vitro. FSH binding to its receptor on the cumulus cells
activates a cAMP–regulated pathway (Tayar, 1996) and generates a
positive stimulus to induce maturation in a gap junction-dependent
manner (Downs, 2001; Downs et al., 1988). The nature of this positive
stimulus and the means by which it brings about GVB remain active
areas of research. We show that FSH stimulation for 3 h is sufficient to
increase ACC phosphorylation in GV-stage mouse oocytes, indicating
AMPK activation. In addition, immunoblotting and immunofluorescent
staining using anti-PT172 antiserum directly showed an increase of
active AMPK in FSH-treated GV-stage oocytes. These observations are
consistent with AMPK involvement in FSH-induced meiotic resumption,
since the kinase is activated prior to meiotic resumption. Support for
this idea was provided by the use of the AMPK inhibitors, compound C
(Zhou et al., 2001) and araA (precursor of araATP, (Henin et al.,
1996)), which blocked both hormone-induced maturation and AMPK
activation.
In a normal reproductive cycle, it is the LH surge that regulates
oocyte maturation in vivo. It has been shown that EGF-like peptides,
such as amphiregulin (AR), epiregulin, and betacellulin, mediate LHinduced effects on oocyte meiotic maturation in rodents (Ashkenazi et
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al., 2005; Hsieh et al., 2007; Park et al., 2004). A model system has
been proposed in which secretion of EGF-like peptides by the mural
granulosa cells in response to gonadotropin stimulation functions in an
autocrine and paracrine manner to transduce the hormone effects in
the follicle (Park et al., 2004). In cultured CEO, FSH induces AR mRNA
expression within 0.5 h by a prostaglandin synthase 2 and
progesterone receptor-dependent mechanism (Shimada et al., 2006).
In addition, a recent study showed that AR mediates FSH-induced
maturation in mouse oocytes in vitro (Downs and Chen, 2007).
Therefore, it was important to test whether AMPK is involved in oocyte
maturation mediated by EGF-like peptides. Indeed, Western analysis
indicated that AR induces AMPK activation in mouse oocytes before
GVB, and this was confirmed by immunocytochemistry. Moreover, as
in FSH-treated CEO, AR-induced oocyte maturation and AMPK
activation were blocked by AMPK inhibitors, further supporting the
involvement of AMPK in AR-induced maturation.
By immunofluorescent staining, we showed that a considerable
portion of active AMPK α subunit accumulated in the germinal vesicle
after AICAR, FSH or AR stimulation in vitro or hCG stimulation in vivo.
Evidence for the active AMPK specificity of this staining stems from its
elimination by treatment of oocytes with compound C or treatment of
antibody with a specific blocking peptide. In Drosophila melanogaster,
the AMPK homologue, DmAMPK, has also been shown to be associated
with the nucleus when it was activated by oligomycin (Pan and Hardie,
2002). Moreover, in yeast, the AMPK homologue, SNF1, translocalizes
from cytoplasm to the nucleus in response to alkaline pH but not
sodium ion stress (Hong and Carlson, 2007). It is tempting to
speculate that active AMPK within the germinal vesicle is important for
its meiosis-inducing action. However, it should be noted that an
increased diffuse cytoplasmic staining was also observed in stimulated
CEO, through it was of lesser intensity.
In mammals, the AMPK catalytic subunit contains two isoforms,
α1 and α2, which are encoded by different genes. In somatic cells, α1AMPK is only present in the cytoplasm, whereas α2 is mainly localized
in the nucleus (Salt et al., 1998; Stapleton et al., 1996; Turnley et al.,
1999). A recent study showed that in a mouse myoblast cell line, α2
and α1 isoforms are both localized in the cytoplasm, while activation of
AMPK results in α2, but not α1, translocation into the nucleus (Suzuki
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et al., 2007). Interestingly, we have observed increased α1 AMPK
accumulation in or around the germinal vesicle of AICAR-stimulated
oocytes (unpublished data), suggesting a movement of this subunit
from the cytoplasm into the GV prior to meiotic resumption. Thus,
different active AMPK isoform dynamics may be manifest in mouse
oocytes when compared to somatic cells, but clarification awaits
further study.
Immunofluorescent staining of oocytes from hCG-stimulated
animals also revealed that AMPK was activated prior to GVB in vivo. An
increase in fluorescence was observed 1 h after hCG injection that
became significantly more intense by 2 h post-hCG. Moreover, as was
observed in oocytes stimulated in vitro by AICAR, FSH or AR, active
AMPK was always observed in association with the condensed
chromosomes of maturing oocytes. Taken together, our data support a
physiological role for AMPK in hormone-induced maturation both in
vitro and in vivo. However, an interesting difference in staining pattern
was observed in that oocytes in vitro tended to have smaller, punctate
staining, while those maturing in vivo had fewer, but larger,
concretions of fluorescence. The significance of these differences is not
known and they provide a challenge for future experimentation.
The observation that active AMPK accumulated around the
periphery of condensed chromosomes in all maturing oocytes suggests
that AMPK participates in subsequent events leading to the completion
of meiosis I, such as the segregation of chromosomes. Indeed, we
have reported increased frequencies of metaphase II oocytes following
in vitro culture in the presence of AICAR (Downs and Chen, 2006). A
study in Saccharomyces cerevisiae has shown that the AMPK
homologue, SNF1, is required for both early (DNA replication and
meiotic recombination) and late (meiotic chromosome segregation and
spore formation) stages of meiosis through different mechanisms
(Honigberg and Lee, 1998). It will be interesting to determine the
pattern of AMPK activation throughout maturation and fertilization in
the mouse and its involvement in these later developmental stages.
Data presented herein and in previous studies have
demonstrated a meiosis-inducing action of AMPK in mouse oocytes.
The present study is important because it implicates AMPK in
hormone-induced oocyte maturation in the mouse, thereby verifying a
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physiological role in meiotic regulation. Curiously, in oocytes from two
other species, cow and pig, AMPK has the opposite action on oocyte
maturation (Bilodeau-Goeseels et al., 2007; Mayes et al., 2007; Tosca
et al., 2007). In a recent study, Mayes et al. (2007) showed that
activation of AMPK transiently suppressed the spontaneous maturation
of pig oocytes, and that this effect was mediated by the cumulus cells.
A similar cumulus cell-dependent inhibitory effect was reported by
Tosca et al (2007) when bovine oocytes were treated with the AMPK
activator, metformin. Bilodeau-Goeseels et al (2007) also reported
suppression of bovine maturation with AICAR and metformin, but
these agents were effective in both CEO and DO. These findings are
striking not only because the response to AMPK activation is one of
meiotic suppression, but also because the site of action may vary
between germ and somatic compartments. Thus, fundamental
differences exist in meiotic regulation of mammalian oocytes that
serve to emphasize the difficulty in extrapolating experimental findings
to another species. As a further example of this, in preliminary
experiments we have been unable to stimulate GVB in rat oocytes with
AICAR or a brief heat shock, both of which are effective meiotic
inducers in mice (Downs et al., 2002; LaRosa and Downs, 2007). It is
apparent that the mouse possesses unique physiological characteristics
associated with the control of meiotic resumption. A future challenge
will be the delineation of similarities as well as differences between
mammalian species in how oocyte maturation is regulated.
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